N/a
-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-April 15 2020: PT increase to 41, Making new ATH's
-April 16 2020: Wins $483 Million US Government Award To Develop Coronavirus Vaccine
-May 01 2020: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Modernas Vaccine (mRNA-1273)
-May 06 2020: Weak earnings / lags estimates, FDA approves phase 2 of COVID-19 vaccine
-Jun 03 2020: MRNA in top 5 pick for vaccine candidate
-Jul 13 2020: MRNA to join NASDAQ 100 Index
-Jul 23 2020: Lost nano particle patent against ABUS, vaccine could be in jeopardy
-SPY pattern: Bowl
-Intraday pattern: Bear Flag
-Other notes: N/a
Strategy: Daily trend line bounce swing
Confluence: N/a
Strike Zone: N/a
Sizing (lots + emergency): 23
Risk (stop / Rs): 66.49
Target was anywhere from 76 to 85, the RR wasn't there for me to take profits at 70 so I held, got stopped out but eh, what can you do..
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-08-14 07:22:00 | MRNA | buy | $68.120 | long |
2020-08-18 10:21:00 | MRNA | sell | $66.400 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!